Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jordi Guzmán-Casta"'
Autor:
Jordi Guzmán‐Casta, Sonia Carrasco‐CaraChards, Jorge Guzmán‐Huesca, Carla Paola Sánchez‐Ríos, Rodrigo Riera‐Sala, José Fabián Martínez‐Herrera, Erika Sagrario Peña‐Mirabal, Diana Bonilla‐Molina, Jorge Arturo Alatorre‐Alexander, Luis Manuel Martínez‐Barrera, Jerónimo Rafael Rodríguez‐Cid
Publikováno v:
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Abstract Background Malignant pleural mesothelioma is an infrequent neoplasia with a poor prognosis and the majority of patients already have advanced disease at the time of presentation. Exposure to asbestos is the most important risk factor for mal
Externí odkaz:
https://doaj.org/article/7bd83ef32c1c460d930b9e6993ead98d
Autor:
Jeronimo Rafael Rodriguez-Cid, Juan Jose Juarez-Vignon Whaley, Gisela Sánchez-Domínguez, Jordi Guzmán-Casta, Sonia Carrasco-CaraChards, Jorge Guzmán-Huesca, Rodrigo Riera-Sala, Carla Paola Sánchez-Ríos, Mayte Cruz-Zermeño, Alec Seidman-Sorsby, Ivan de Jesús Rodríguez-Zea, Jorge Arturo Alatorre-Alexander, Luis Manuel Martínez-Barrera, Patricio Javier Santillán-Doherty, Aminadab Godina-Flores, Victoria Imaz-Olguin, Ricardo Sosa-Sánchez, Dan Green-Renner
Publikováno v:
Journal of cancer research and clinical oncology.
Thoracic sarcomas are rare malignancies, with limited data for unresectable/advanced scenarios. Our goal is to provide insights of a three-drug chemotherapy regimen improving patient survival compared to standard regimens.Retrospective cohort analysi
Autor:
Jerónimo R. Rodriguez-Cid, Juan J. Juarez-Vignon Whaley, Gisela Sánchez-Domínguez, Jordi Guzmán-Casta, Sonia Carrasco-CaraChards, Jorge A. Alatorre-Alexander, Luis M. Martínez-Barrera, Carla P. Sánchez-Rios, Rodrigo R. Flores-Mariñelarena, Alec Seidman-Sorsby, Mayte Cruz-Zermeño, Ivan J. Rodríguez-Zea, Patricio J. Santillan-Doherty
Publikováno v:
Journal of thoracic disease. 14(9)
Primary thoracic sarcomas (PTS) including primary pulmonary and chest wall sarcomas (CWS), are aggressive lung malignancies with limited information specially in an advanced/unresectable setting. Unfortunately, prognostic factors for these malignanci
Autor:
Julio César Garibay-Díaz, José Fabián Martínez-Herrera, Carla Paola Sánchez-Ríos, Julián Diaz-Rico, Jerónimo Rafael Rodríguez-Cid, Adriana Martinez-Camacho, Luis Manuel Martínez-Barrera, Jorge Arturo Alatorre-Alexander, Rodrigo Riera-Sala, Rodrigo Rafael Flores-Mariñelarena, Patricio Santillán-Doherty, Iván Romarico González-Espinoza, Anna Gozalishvili-Boncheva, Sonia Carrasco-Cara Chards, Vanessa García-Montes, Jordi Guzmán-Casta, Osvaldo Hernández-Flores
Publikováno v:
Lung Cancer Management
Background: Immunotherapy has demonstrated an improved overall survival (OS) and progression-free survival (PFS) as second-line treatment and subsequent lines compared with chemotherapy. Materials and methods: This was a retrospective review among ei
Autor:
Jordi Guzmán-Casta, Rodrigo Riera-Sala, Luis Manuel Martínez-Barrera, Jerónimo Rafael Rodríguez-Cid, Carla Paola Sánchez-Ríos, Diana Bonilla-Molina, Sonia Carrasco-CaraChards, Erika Sagrario Peña-Mirabal, Jorge Arturo Alatorre-Alexander, Jorge Guzmán-Huesca, José Fabián Martínez-Herrera
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Thoracic Cancer, Vol 12, Iss 7, Pp 1014-1022 (2021)
Background Malignant pleural mesothelioma is an infrequent neoplasia with a poor prognosis and the majority of patients already have advanced disease at the time of presentation. Exposure to asbestos is the most important risk factor for malignant pl